Silverback Therapeutics Inc (SBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SBTX | ZNTL | INBX | ||
| Company | Silverback Therapeutics Inc | Zentalis Pharmaceuticals Inc | Inhibrx Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.82 | 2.90 | 13.70 | ||
| High | 6.15 | 3.10 | 14.72 | ||
| Low | 5.72 | 2.89 | 13.51 | ||
| Last | 5.87 | 3.00 | 14.60 | ||
| Change | +0.06 | +0.07 | +0.72 | ||
| % Change | +1.03% | +2.39% | +5.19% | ||
| Volume | 116,700 | 1,854,000 | 270,800 | ||
| 20-Day Average Volume | 195,280 | 1,051,455 | 81,355 | ||
| Previous Close | 5.81 | 2.93 | 13.88 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.79 | 3.35 | 14.87 | ||
| 20-Day Raw Stochastic | 60.38% | 17.01% | 40.52% | ||
| 20-Day Relative Strength | 54.62% | 43.70% | 47.08% | ||
| Weighted Alpha | -17.00 | -72.59 | -8.03 | ||
| Today's Opinion | 100% Buy | 80% Sell | N/A | ||
| Previous Opinion | 100% Buy | 80% Sell | N/A | ||
| Last Month's Opinion | 56% Buy | 96% Sell | N/A | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.55% since 11/01/22 | -2.91% since 12/13/24 | -0.14% since 12/13/24 | ||
| Low | 5.72 on 11/08/22 | 2.80 on 12/19/24 | 13.51 on 12/20/24 | ||
| High | 6.46 on 11/02/22 | 3.25 on 12/17/24 | 15.24 on 12/18/24 | ||
| 1-Month | |||||
| %Chg | +11.81% since 10/07/22 | -4.15% since 11/20/24 | +3.99% since 11/20/24 | ||
| Low | 4.91 on 10/13/22 | 2.80 on 12/19/24 | 13.51 on 12/20/24 | ||
| High | 6.50 on 10/31/22 | 4.00 on 12/09/24 | 16.20 on 11/29/24 | ||
| 3-Month | |||||
| %Chg | +17.87% since 08/08/22 | -28.91% since 09/20/24 | -10.32% since 09/20/24 | ||
| Low | 4.45 on 09/23/22 | 2.66 on 10/31/24 | 12.25 on 11/15/24 | ||
| High | 6.50 on 10/31/22 | 4.44 on 11/13/24 | 17.41 on 11/12/24 | ||
| 6-Month | |||||
| %Chg | +94.37% since 05/06/22 | -42.86% since 06/20/24 | +0.76% since 06/20/24 | ||
| Low | 2.80 on 05/12/22 | 2.66 on 10/31/24 | 10.80 on 08/12/24 | ||
| High | 6.50 on 10/31/22 | 5.47 on 06/21/24 | 17.79 on 09/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 211,660 | 213,795 | 211,349 | ||
| Shares Outstanding, K | 36,058 | 71,265 | 14,476 | ||
| Annual Sales | 0 | 0 | 1,630,000 | ||
| Annual Net Income | -89,480,000 | -292,190,000 | -154,960,000 | ||
| Last Quarter Sales | 0 | 0 | 100,000 | ||
| Last Quarter Net Income | -17,860,000 | -88,280,000 | 1,858,010,000 | ||
| 60-Month Beta | 0.60 | 1.84 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.50 on 11/02/22 | -0.56 on 11/12/24 | -2.84 on 11/14/24 | ||
| Latest Earnings Date | 11/09/22 | 11/18/24 | 02/13/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||